Shogo Yamamoto
- Biochemistry top 0.2%
- Eicosanoids and Hypertension Pharmacology 18
- Pharmacology top 0.2%
- Inflammatory mediators and NSAID effects 26
- Cancer Research top 2%
- Molecular Biology top 1%
- Microbial Metabolic Engineering and Bioproduction 11
- Epigenetics and DNA Methylation 11
- Peroxisome Proliferator-Activated Receptors 10
- RNA modifications and cancer 8
- Toxicology top 1%
-
- Estrogen and related hormone effects 12
-
- Pancreatic and Hepatic Oncology Research 8
- Co-authors
- Osamu HayaishiN OginoHiroyuki AburataniNatsuo UedaTsumoru MiyamotoT YoshimotoS. OhkiMasayuki Inui
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Journal of Biological Chemistry (25 papers)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Shogo Yamamoto
188 papers receiving 7.7k citations
Hit Papers
Peers
Comparison fields: 5 of 149
- Biochemistry 1.1k
- Pharmacology 1.9k
- Cancer Research 917
- Molecular Biology 4.0k
- Toxicology 191
Countries citing papers authored by Shogo Yamamoto
This map shows the geographic impact of Shogo Yamamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shogo Yamamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shogo Yamamoto more than expected).
Fields of papers citing papers by Shogo Yamamoto
This network shows the impact of papers produced by Shogo Yamamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shogo Yamamoto. The network helps show where Shogo Yamamoto may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shogo Yamamoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2020 | 1 | |
| 3 | 2020 | 2 | |
| 4 | 2020 | 151 | |
| 5 | 2020 | 22 | |
| 6 | 2020 | 77 | |
| 7 | 2019 | 26 | |
| 8 | 2019 | 25 | |
| 9 | 2016 | 49 | |
| 10 | 2016 | 23 | |
| 11 | 2010 | 83 | |
| 12 | 2008 | 70 | |
| 13 | 2007 | 15 | |
| 14 | 1999 | 3 | |
| 15 | A hydrolase enzyme inactivating endogenous ligands for cannabinoid receptors. | 1998 | 20 |
| 16 | Transcriptional regulation of fatty acid cyclooxygenases-1 and -2. | 1998 | 16 |
| 17 | 1997 | 10 | |
| 18 | 1995 | 70 | |
| 19 | 1994 | 11 | |
| 20 | 1994 | 17 |
About Shogo Yamamoto
Shogo Yamamoto is a scholar working on Biochemistry, Pharmacology and Toxicology, having authored 196 papers that have together received 7.9k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (26 papers), Eicosanoids and Hypertension Pharmacology (18 papers), Estrogen and related hormone effects (12 papers), Microbial Metabolic Engineering and Bioproduction (11 papers), Epigenetics and DNA Methylation (11 papers), Peroxisome Proliferator-Activated Receptors (10 papers), RNA modifications and cancer (8 papers) and Pancreatic and Hepatic Oncology Research (8 papers). The work is most often cited by research in Biochemistry (1.1k citations), Pharmacology (1.9k citations) and Cancer Research (917 citations). Shogo Yamamoto has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Osamu Hayaishi, N Ogino, Hiroyuki Aburatani, Natsuo Ueda, Tsumoru Miyamoto, T Yoshimoto, S. Ohki, Masayuki Inui, Yutaka Midorikawa and Hideaki Yukawa. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.